ACADIA PHARMACEUTICALS INC (ACAD) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $298K. Most recent filing: Aug. 7, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 7, 2026 filed Aug. 5, 2026 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | — | 0 | 0% | Yes | |
|
|
||||||
| July 31, 2026 filed July 29, 2026 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | — | +15,714 | +479% | No | |
|
|
||||||
| June 29, 2026 filed June 26, 2026 | Kihara James PRINCIPAL ACCOUNTING OFFICER | −$297,912 | 11,421 | −47% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free